FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3931411000001109: Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26559301000001116 Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
66040501000001114 Orelox 40mg/5ml oral suspension paediatric (Sanofi) 100 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Is a Cefpodoxime 40mg/5ml oral suspension 100 ml true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Is pack of Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has active ingredient Cefpodoxime proxetil false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has active ingredient Cefpodoxime false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has excipient Aspartame false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has excipient Lactose false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has AMP Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cefpodoxime true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has specific active ingredient Cefpodoxime proxetil true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has basis of strength substance Cefpodoxime true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start